Par Drugs and Chemicals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
For the nine months, sales was INR 712.57 million compared to INR 529.94 million a year ago. Revenue was INR 714.64 million compared to INR 531.11 million a year ago. Net income was INR 78.87 million compared to INR 67.91 million a year ago. Basic earnings per share from continuing operations was INR 6.41 compared to INR 5.52 a year ago. Diluted earnings per share from continuing operations was INR 6.41 compared to INR 5.52 a year ago.